These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15159039)
1. A comparison of HDL and LDL cholesterol for prevalent coronary calcification. Allison MA; Wright CM Int J Cardiol; 2004 May; 95(1):55-60. PubMed ID: 15159039 [TBL] [Abstract][Full Text] [Related]
2. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population. Huang YC; Ho CC; Lin PT; Lee BJ; Lai CH; Liaw YP Nutr Res; 2010 Jan; 30(1):21-6. PubMed ID: 20116656 [TBL] [Abstract][Full Text] [Related]
3. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol. Grover SA; Dorais M; Coupal L Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032 [TBL] [Abstract][Full Text] [Related]
4. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). Shlipak MG; Chaput LA; Vittinghoff E; Lin F; Bittner V; Knopp RH; Hulley SB; Am Heart J; 2003 Nov; 146(5):870-5. PubMed ID: 14597937 [TBL] [Abstract][Full Text] [Related]
5. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Hadaegh F; Harati H; Ghanbarian A; Azizi F Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508 [TBL] [Abstract][Full Text] [Related]
7. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study. Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525 [TBL] [Abstract][Full Text] [Related]
8. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227 [TBL] [Abstract][Full Text] [Related]
9. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002). Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140 [TBL] [Abstract][Full Text] [Related]
10. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events. Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. Grover SA; Kaouache M; Joseph L; Barter P; Davignon J Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435 [TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of high-density lipoproteins in the cardiology unit]. Sampietro T; Bigazzi F; Dal Pino B; Landi P; Puntoni M; Minichilli F; Bianchi F; Chella E; Carpeggiani C; Bionda A Ital Heart J Suppl; 2004 Sep; 5(9):720-6. PubMed ID: 15568610 [TBL] [Abstract][Full Text] [Related]
14. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information? Holcombe SM; Brubaker PH J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073 [TBL] [Abstract][Full Text] [Related]
15. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children. Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339 [TBL] [Abstract][Full Text] [Related]
16. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lipoprotein fractions in essential hypertension. Verdecchia P; Reboldi G; Angeli F; Gattobigio R; Borgioni C; Filippucci L; Poeta F; Porcellati C Blood Press; 2004; 13(5):295-303. PubMed ID: 15545153 [TBL] [Abstract][Full Text] [Related]